An Imaging Study for Patients with Non-Alcoholic Steatohepatitis

This simple study investigates how a new MRI technology (LiverMultiscan software) is able to identify patients with a NAFLD activity score (NAS) ≥ 4 and liver fibrosis ≥ stage 2, compared to the histopathologic reference standard.

In order to participate you must meet the following criteria:

• Have non-alcoholic steatohepatitis (NASH).
• Have a standard of care liver biopsy ordered by your physician.

You will be excluded from the study if any of the following criteria apply to you:

• Have had NASH diagnosed with a liver biopsy within the previous 5 years.
• Have a history or diagnosis of cirrhosis and/or hepatic decompensation including ascites, hepatic encephalopathy or variceal bleeding.

This is a partial list of eligibility requirements. To inquire about your eligibility, please call the contact number provided. If you wish to inquire via email, please include the title of the study in your message.